Cannabidivarin is Anticonvulsant in Mouse and Rat

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2012 Sep 14

PMID 22970845

Citations 68

Authors

A J Hill

M S Mercier

T D M Hill

S E Glyn

N A Jones

Y Yamasaki

T Futamura

M Duncan

C G Stott

G J Stephens

C M Williams

B J Whalley

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Phytocannabinoids in Cannabis sativa have diverse pharmacological targets extending beyond cannabinoid receptors and several exert notable anticonvulsant effects. For the first time, we investigated the anticonvulsant profile of the phytocannabinoid cannabidivarin (CBDV) in vitro and in in vivo seizure models.

Experimental Approach: The effect of CBDV (1-100 μM) on epileptiform local field potentials (LFPs) induced in rat hippocampal brain slices by 4-aminopyridine (4-AP) application or Mg(2+) -free conditions was assessed by in vitro multi-electrode array recordings. Additionally, the anticonvulsant profile of CBDV (50-200 mg·kg(-1) ) in vivo was investigated in four rodent seizure models: maximal electroshock (mES) and audiogenic seizures in mice, and pentylenetetrazole (PTZ) and pilocarpine-induced seizures in rats. The effects of CBDV in combination with commonly used antiepileptic drugs on rat seizures were investigated. Finally, the motor side effect profile of CBDV was investigated using static beam and grip strength assays.

Key Results: CBDV significantly attenuated status epilepticus-like epileptiform LFPs induced by 4-AP and Mg(2+) -free conditions. CBDV had significant anticonvulsant effects on the mES (≥100 mg·kg(-1) ), audiogenic (≥50 mg·kg(-1) ) and PTZ-induced seizures (≥100 mg·kg(-1) ). CBDV (200 mg·kg(-1) ) alone had no effect against pilocarpine-induced seizures, but significantly attenuated these seizures when administered with valproate or phenobarbital at this dose. CBDV had no effect on motor function.

Conclusions And Implications: These results indicate that CBDV is an effective anticonvulsant in a broad range of seizure models. Also it did not significantly affect normal motor function and, therefore, merits further investigation as a novel anti-epileptic in chronic epilepsy models.

Linked Articles: This article is part of a themed section on Cannabinoids. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.167.issue-8.

Citing Articles

Unveiling the Potential of Phytocannabinoids: Exploring Marijuana's Lesser-Known Constituents for Neurological Disorders.

Basavarajappa B, Subbanna S Biomolecules. 2024; 14(10).

PMID: 39456229 PMC: 11506053. DOI: 10.3390/biom14101296.

Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder.

Massey S, Quigley A, Rochfort S, Christodoulou J, Van Bergen N Int J Mol Sci. 2024; 25(19).

PMID: 39409097 PMC: 11476665. DOI: 10.3390/ijms251910768.

Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ-THC through the 5-HT1A Receptor in the Neocortex of Mice.

Javadzadeh Y, Santos A, Aquilino M, Mylvaganam S, Urban K, Carlen P Cells. 2024; 13(6.

PMID: 38534310 PMC: 10969448. DOI: 10.3390/cells13060466.

Cannabidiol-Based Prodrugs: Synthesis and Bioevaluation.

Singh Cham P, Kotwal P, Sharma K, Dhiman S, Singh L, Pratap Singh V ACS Med Chem Lett. 2024; 15(2):221-229.

PMID: 38352838 PMC: 10860190. DOI: 10.1021/acsmedchemlett.3c00461.

Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP.

Bosco F, Guarnieri L, Leo A, Tallarico M, Gallelli L, Rania V Front Neurol. 2023; 14:1223074.

PMID: 37681009 PMC: 10481168. DOI: 10.3389/fneur.2023.1223074.

References

De Petrocellis L, Ligresti A, Moriello A, Allara M, Bisogno T, Petrosino S . Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2010; 163(7):1479-94. PMC: 3165957. DOI: 10.1111/j.1476-5381.2010.01166.x. View

Stanley J, Lincoln R, Brown T, McDonald L, Dawson G, Reynolds D . The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines. J Psychopharmacol. 2005; 19(3):221-7. DOI: 10.1177/0269881105051524. View

Lindekens H, Smolders I, Khan G, Bialer M, Ebinger G, Michotte Y . In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy. Pharm Res. 2001; 17(11):1408-13. DOI: 10.1023/a:1007559208599. View

Kwan P, Brodie M . Emerging drugs for epilepsy. Expert Opin Emerg Drugs. 2007; 12(3):407-22. DOI: 10.1517/14728214.12.3.407. View

Ryan D, Drysdale A, Lafourcade C, Pertwee R, Platt B . Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. J Neurosci. 2009; 29(7):2053-63. PMC: 6666323. DOI: 10.1523/JNEUROSCI.4212-08.2009. View

Cavanaugh D, Chesler A, Jackson A, Sigal Y, Yamanaka H, Grant R . Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci. 2011; 31(13):5067-77. PMC: 3087977. DOI: 10.1523/JNEUROSCI.6451-10.2011. View

Ross H, Napier I, Connor M . Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol. J Biol Chem. 2008; 283(23):16124-34. PMC: 3259625. DOI: 10.1074/jbc.M707104200. View

ElSohly M, Slade D . Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 2005; 78(5):539-48. DOI: 10.1016/j.lfs.2005.09.011. View

Luszczki J, Filip D, Czuczwar S . Additive interactions of pregabalin with lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis for non-parallel dose-response relationship curves. Epilepsy Res. 2010; 91(2-3):166-75. DOI: 10.1016/j.eplepsyres.2010.07.009. View

10.

Shantilal P, David J, Joseph T . Effect of sodium valproate and flunarizine administered alone and in combination on pentylenetetrazole model of absence seizures in rat. Indian J Exp Biol. 2000; 37(3):228-33. View

11.

Cunha J, Carlini E, Pereira A, Ramos O, Pimentel C, Gagliardi R . Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology. 1980; 21(3):175-85. DOI: 10.1159/000137430. View

12.

Sirven J, Berg A . Marijuana as a treatment for epilepsy and multiple sclerosis? A "grass roots" movement. Neurology. 2004; 62(11):1924-5. DOI: 10.1212/01.wnl.0000129703.59857.d6. View

13.

Loscher W . Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure. 2011; 20(5):359-68. DOI: 10.1016/j.seizure.2011.01.003. View

14.

Mezey E, Toth Z, Cortright D, Arzubi M, Krause J, Elde R . Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A. 2000; 97(7):3655-60. PMC: 16295. DOI: 10.1073/pnas.97.7.3655. View

15.

Crofton K, Padilla S, Tilson H, Anthony D, Raymer J, MacPhail R . The impact of dose rate on the neurotoxicity of acrylamide: the interaction of administered dose, target tissue concentrations, tissue damage, and functional effects. Toxicol Appl Pharmacol. 1996; 139(1):163-76. DOI: 10.1006/taap.1996.0155. View

16.

Muller K, Ryals J, Feldman E, Wright D . Abnormal muscle spindle innervation and large-fiber neuropathy in diabetic mice. Diabetes. 2008; 57(6):1693-701. DOI: 10.2337/db08-0022. View

17.

Izzo A, Borrelli F, Capasso R, Di Marzo V, Mechoulam R . Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009; 30(10):515-27. DOI: 10.1016/j.tips.2009.07.006. View

18.

Coenen A, van Luijtelaar E . Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of rats. Behav Genet. 2003; 33(6):635-55. DOI: 10.1023/a:1026179013847. View

19.

Consroe P, Benedito M, Leite J, Carlini E, Mechoulam R . Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice. Eur J Pharmacol. 1982; 83(3-4):293-8. DOI: 10.1016/0014-2999(82)90264-3. View

20.

Sofia R, Gordon R, Gels M, Diamantis W . Effects of felbamate and other anticonvulsant drugs in two models of status epilepticus in the rat. Res Commun Chem Pathol Pharmacol. 1993; 79(3):335-41. View